Clinical Trial Update: Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating simvastatin in amnestic mild cognitive impairment (MCI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Mild Cognitive Impairment | Phase 4 | Status: UNKNOWN